Login

OncoMed Pharmaceuticals Inc SEC Filings

Filed On Filing
03 May 2019 FORM 15-12B
26 Apr 2019 AMENDMENT NO. 1 TO THE SCHEDULE 13D
24 Apr 2019 FORM S-8 POS
24 Apr 2019 FORM S-8 POS
24 Apr 2019 FORM S-8 POS
24 Apr 2019 FORM S-8 POS
24 Apr 2019 FORM S-8 POS
24 Apr 2019 FORM S-8 POS
23 Apr 2019 Form 4: Hager Alicia J., SVP and General Counsel

Disposed of 39,488 shares (Tender Offer)

23 Apr 2019 Form 4: Root Jonathan D, Director

Disposed of 121,020 shares (Tender Offer)

23 Apr 2019 Form 4: Lasersohn Jack W, Director

Disposed of 1,685,913 shares (Tender Offer)

23 Apr 2019 Form 4: Lewicki John A., Director

Disposed of 142,534 shares (Tender Offer)

23 Apr 2019 Form 4: Pakianathan Deepika, Director

Disposed of 2,010,542 shares (Tender Offer)

23 Apr 2019 Form 4: Li Yvonne, See Remarks

Disposed of 65,895 shares (Tender Offer)

23 Apr 2019 Form 4: Stagg Robert, See Remarks

Disposed of 28,917 shares (Tender Offer)

23 Apr 2019 Form 4: Karsen Perry A, Director

Disposed of 80,500 shares (Tender Offer)

23 Apr 2019 25-NSE
23 Apr 2019 8-K: Completion of Acquisition or Disposition of Assets; Notice of Delisting or Failure to Satisfy a Listing Rule +4 more
17 Apr 2019 8-K
17 Apr 2019 8-K: Submission of Matters to a Vote of Security Holders; Other Events

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support